SCHEMBL30847788

SCHEMBL30847788

COC(C)c1ccnc(Cl)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MALT1 Q9UDY8 1/20 0.38
RECQL P46063 1/20 0.37
LOX P28300 1/20 0.37
LOXL3 P58215 1/20 0.37
LOXL2 Q9Y4K0 1/20 0.37
AKR1C2 P52895 1/20 0.35
AKR1C1 Q04828 1/20 0.35
ROCK2 O75116 1/20 0.34
ROCK1 Q13464 1/20 0.34
TRPA1 O75762 1/20 0.34
POLB P06746 1/20 0.34
OPRM1 P35372 1/20 0.33
OPRK1 P41145 1/20 0.33
KCNH2 Q12809 1/20 0.33
PFKFB3 Q16875 1/20 0.33
NFE2L2 Q16236 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15877446 1.00 MALT1 (0.38) MALT1RECQLLOXLOXL3LOXL2
SCHEMBL4651277 0.82 RECQL (0.38) MALT1RECQLLOXLOXL3LOXL2
SCHEMBL2759112 0.79 RECQL (0.42) RECQLLOXLOXL3LOXL2TRPA1
SCHEMBL7993514 0.78 RECQL (0.41) RECQLLOXLOXL3LOXL2AKR1C2
SCHEMBL27752251 0.78 SMARCA2 (0.38) MALT1RECQLAKR1C2ROCK2ROCK1
SCHEMBL15260015 0.78 NFE2L2 (0.35) MALT1RECQLLOXLOXL3LOXL2
SCHEMBL27146027 0.77 RECQL (0.38) RECQLLOXLOXL3LOXL2AKR1C2
SCHEMBL23475190 0.76 RECQL (0.39) RECQLLOXLOXL3LOXL2AKR1C2
SCHEMBL24724094 0.76 RECQL (0.44) RECQLLOXLOXL3LOXL2ROCK2
SCHEMBL2040052 0.76 RECQL (0.44) RECQLLOXLOXL3LOXL2AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 WO disclosed